These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21325656)

  • 1. Coexistence of late gadolinium enhancement due to myocardial infarction and hypertrophic cardiomyopathy.
    Lin D; Lesser JR; Maron BJ
    Heart; 2011 May; 97(10):861-2. PubMed ID: 21325656
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is late gadolinium enhancement in hypertrophic cardiomyopathy?].
    Moon JC
    Rev Esp Cardiol; 2007 Jan; 60(1):1-4. PubMed ID: 17288947
    [No Abstract]   [Full Text] [Related]  

  • 3. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
    J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy mimicking acute myocardial infarction: diagnostic role of cardiac magnetic resonance.
    Di Bella G; Bramanti O; Russo MS; Migliorato A; Anfuso C; Minutoli F; Arrigo F; Coglitore S
    Int J Cardiol; 2008 Apr; 125(3):e34-6. PubMed ID: 17368585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathy.
    Romero-Puche A; Marín F; González-Carrillo J; García-Honrubia A; Climent V; Feliu E; Ruiz-Espejo F; Payá E; Gimeno-Blanes JR; de la Morena G; Valdés-Chavarri M
    Rev Esp Cardiol; 2008 Aug; 61(8):853-60. PubMed ID: 18684368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.
    McCrohon JA; Moon JC; Prasad SK; McKenna WJ; Lorenz CH; Coats AJ; Pennell DJ
    Circulation; 2003 Jul; 108(1):54-9. PubMed ID: 12821550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity.
    Aquaro GD; Masci P; Formisano F; Barison A; Strata E; Pingitore A; Positano V; Spirito P; Lombardi M
    Am J Cardiol; 2010 Feb; 105(3):392-7. PubMed ID: 20102955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy.
    Ismail TF; Prasad SK; Pennell DJ
    Heart; 2012 Mar; 98(6):438-42. PubMed ID: 22128204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myocardial infarction with diminutive right coronary artery and obstructive hypertrophic cardiomyopathy without significant coronary stenoses.
    Patanè S; Marte F; Di Bella G; Chiribiri A
    Int J Cardiol; 2009 Jul; 135(3):e73-5. PubMed ID: 18639352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
    Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
    Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial fibrosis and regional function in hypertrophic cardiomyopathy: may the force be with you.
    Carasso S; Rakowski H
    J Am Soc Echocardiogr; 2008 Dec; 21(12):1306-8. PubMed ID: 19041573
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy.
    Lehrke S; Lossnitzer D; Schöb M; Steen H; Merten C; Kemmling H; Pribe R; Ehlermann P; Zugck C; Korosoglou G; Giannitsis E; Katus HA
    Heart; 2011 May; 97(9):727-32. PubMed ID: 21097819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy.
    Fattori R; Biagini E; Lorenzini M; Buttazzi K; Lovato L; Rapezzi C
    Am J Cardiol; 2010 Jun; 105(11):1592-6. PubMed ID: 20494668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed enhancement morphology on cardiac magnetic resonance imaging is correlated with signal-averaged electrocardiogram and QT dispersion in myocardial infarction.
    Takase B; Nagata M
    Angiology; 2009; 60(4):412-8. PubMed ID: 19124453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic ventricular tachyarrhythmia is associated with delayed gadolinium enhancement in cardiac magnetic resonance imaging and with elevated plasma brain natriuretic peptide level in hypertrophic cardiomyopathy.
    Oka K; Tsujino T; Nakao S; Lee-Kawabata M; Ezumi A; Masai M; Ohyanagi M; Masuyama T
    J Cardiol; 2008 Oct; 52(2):146-53. PubMed ID: 18922389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare variant of single coronary artery and non-obstructive hypertrophic cardiomyopathy.
    Atmaca Y; Dandachi R; Oral D
    J Invasive Cardiol; 2002 Aug; 14(8):469-70. PubMed ID: 12147880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Images in cardiovascular medicine. Hypertrophic cardiomyopathy with apical aneurysm.
    Zenovich AG; Lesser JR; Casey SA; Maron BJ
    Circulation; 2004 Oct; 110(16):e450. PubMed ID: 15492326
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy.
    Spiewak M; Malek LA; Misko J; Chojnowska L; Milosz B; Klopotowski M; Petryka J; Dabrowski M; Kepka C; Ruzyllo W
    Eur J Radiol; 2010 Jun; 74(3):e149-53. PubMed ID: 19523780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular magnetic resonance myocardial perfusion coupled with infarct imaging in patients with coronary artery disease.
    Bucciarelli-Ducci C; Francone M; Scardala R; Fedele F
    Minerva Cardioangiol; 2007 Aug; 55(4):521. PubMed ID: 17653031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.